Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy

Metabolism: Clinical and Experimental

Volumn 64, Issue 9, 2015, Pages 958-966

  Kaviarasan, Kuppan ^a   Jithu, Mohanlal ^a   Arif Mulla, Mohammad ^b   Sharma, Tarun ^b   Sivasankar, Shanmuganathan ^a   Das, Undurti Narasimha ^c,d   Angayarkanni, Narayanasamy ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b MEDICAL RESEARCH FOUNDATION   (India)

^c GVP Hospital   (India)

^d UND Life Sciences   (United States)

Author keywords

Cytokines; Diabetic retinopathy; LXA4; Type 2 diabetes

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOXIN A; VASCULOTROPIN; CYTOKINE; LIPOPOLYSACCHARIDE; LIPOXIN; VASCULOTROPIN A;

ADULT; ARTICLE; BIOCHEMICAL ANALYSIS; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON PROLIFERATIVE DIABETIC RETINOPATHY; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; PROTEIN EXPRESSION; RISK FACTOR; TH1 CELL; TH2 CELL; VITREOUS BODY; AGED; BLOOD; CELL LINE; COMPLICATION; CYTOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RETINA; TH1 TH2 BALANCE;

ADULT; AGED; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; CELL LINE; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; IN VITRO TECHNIQUES; LIPOPOLYSACCHARIDES; LIPOXINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINA; RISK FACTORS; TH1-TH2 BALANCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84939562018     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.04.005     Document Type: Article

References (46)

1. U.N. Das Is metabolic syndrome X an inflammatory condition? Exp Biol Med (Maywood) 227 2002 989 997
2. A.D. Pradhan, J.E. Manson, N. Rifai, and et al. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327
3. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
4. E. Larger Hyperglycemia and angiogenesis Med Sci (Paris) 19 2003 840 846
5. M. Lu, M. Kuroki, S. Amano, M. Tolentino, K. Keough, I. Kim, and et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression J Clin Invest 101 1998 1219 1224
6. M. Kuroki, E.E. Voest, S. Amano, and et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo J Clin Invest 98 1996 495 504
7. Q. Ma, J.H. Shen, S.R. Sheng-rong Shen, and et al. Bioactive lipids in pathological retinopathy Crit Rev Food Sci Nutr 54 1 2014 1 16
8. A.P. Adamis Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 86 2002 363 365
9. R.S. Cotran Inflammation: Historical perspectives J.I. Gallin, R. Snyderman, Inflammation: Basic principles and clinical correlates 3rd ed. 1999 Lippincott Williams & Wilkins Philadelphia 5 10 [Chapter 1]
10. D.V. Nguyen, L.C. Shaw, and M.B. Grant Inflammation in the pathogenesis of microvascular complications in diabetes Front Endocrinol 3 2012 170
11. J. Tombran-Tink, G.G. Chader, and L.V. Johnson PEDF: A pigment epithelium-derived factor with potent neuronal differentiative activity Exp Eye Res 53 3 1991 411 414
12. N. Angayarkanni, R. Selvi, R. Pukhraj, and et al. Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease J Ocul Biol Dis Infor 62 1 2009 20 28
13. N. Ogata, M. Matsuoka, K. Matsuyama, and et al. Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy J Clin Endocrinol Metab 92 3 2007 1176 1179
14. A. Jenkins, S.X. Zhang, A. Gosmanova, and et al. Increased serum pigment epithelium derived factor levels in type 2 diabetes patients Diabetes Res Clin Pract 82 1 2008 e5 e7
15. C.N. Serhan, M. Hamberg, and B. Samuelsson Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes Proc Natl Acad Sci 81 1984 5335 5339
16. S. Fiorucci, J.L. Wallace, A. Mencarelli, and et al. A beta-oxidation resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction Proc Natl Acad Sci 101 2004 15736 15741
17. C.N. Serhan Lipoxins and aspirin triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution Prostaglandins Leukot Essent Fatty acids 73 2005 141 162
18. E. Borgeson, F.C. Mcgillicuddy, K.A. Harford, and et al. Lipoxin A4 attenuates adipose inflammation FASEB J 26 2012 4287 4294
19. E. Borgeson, and C. Godson Molecular circuits of resolution in renal disease Sci World J 10 2010 1370 1385
20. N. Baker, S.J. OMeara, M. Scannell, and et al. Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells J Immunol 182 2009 3819 3826
21. E.J. Huang, and L.F. Reichardt Neurotrophins: roles in neuronal development and function Annu Rev Neurosci 24 2001 677 736
22. M. Ono, J. Ichihara, T. Nonomura, and et al. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice Biochem Biophys Res Commun 238 1997 633 637
23. T. Nakagawa, A. Tsuchida, Y. Itakura, and et al. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice Diabetes 49 2000 436 444
24. T. Nonomura, A. Tsuchida, M. Ono-Kishinom, and et al. Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice Int J Exp Diabetes Res 2 2001 201 209
25. M. Seki, T. Tanaka, H. Nawa, and et al. Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells Diabetes 53 2004 2412 2419
26. M. Sasaki, Y. Ozawa, T. Kurihara, and et al. Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes Diabetologia 53 2010 971 979
27. M. Toyomoto, M. Ohta, K. Okumura, and et al. Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures FEBS Lett 562 2004 211 215
28. U. Vetrivel, S. Baarathi, K. Kuppan, and et al. Agonistic effect of polyunsaturated fatty acids (PUFAs) and its metabolites on brain-derived neurotrophic factor (BDNF) through molecular docking simulation Lipids Health Dis 11 2012 109
29. S. Kern Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy Exp Diabetes Res 95103 2007 10.1155/2007/95103
30. E.J. Duh, H.S. Yang, J.A. Haller, and et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis Am J Ophthalmol 137 4 2004 668 674
31. S. Wang, J.L. Gottlieb, C.M. Sorenson, and et al. Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes Arch Ophthalmol 127 4 2009 507 513
32. A.M. Abu El-Asrar, G. Mohammad, G. De Hertogh, and et al. Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy PLoS One 78 6 2013 e65472
33. K.S. Krabbe, A.R. Nielsen, R. Krogh-Madsen, and et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes Diabetologia 50 2007 431 438
34. B.I. Goldstein, K.A. Collinger, F. Lotrich, and et al. Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders J Child Adolesc Psychopharmacol 21 5 2011 479 484
35. G. Bikbova, T. Oshitari, T. Baba, and et al. Neurotrophic factors for retinal ganglion cell neuropathy - with a special reference to diabetic neuropathy in the retina Curr Diabetes Rev 10 3 2014 166 176
36. W. Shuang, K.P. James, and J.D. Elia Novel targets against retinal angiogenesis in diabetic retinopathy Curr Diab Rep 12 2012 355 363
37. A.D. Meleth, E. Agron, C.C. Chan, and et al. Serum inflammatory markers in diabetic retinopathy Invest Ophthalmol Vis Sci 46 2005 4295 4301
38. S. Doganay, C. Evereklioglu, H. Er, and et al. Comparison of serum NO, TNFalpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus Eye 16 2002 163 170
39. J.H. Lee, W. Lee, O.H. Kwon, and et al. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy Ann Clin Lab Sci 38 4 2008 361 367
40. Y. Jiang, N. Wei, J. Zhu, and et al. Effects of Brain derived neurotrophic factor on local inflammation in experimental stroke of rat Mediators Inflamm 372423 2010 10.1155/2010/372423
41. M. Ming, X. Li, X. Fan, and et al. Retinal pigment epithelial cells secretes neurotrophic factors and synthesizes dopamine: possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease J Transl Med 7 2009 53 60
42. R. Simo, M. Villarroel, L. Corraliza, C. Hernández, and M. Garcia-Ramirez The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier - implications for the pathogenesis of diabetic retinopathy J Biomed Biotechnol 2010 2010 190724 10.1155/2010/190724
43. J.F. Parkinson Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation Inflamm Allergy Drug Targets 5 2 2006 91 106
44. C. Bonnans, P. Chanez, and C. Chavis Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation? Allergy 59 10 2004 1027 1041
45. J.L. Wallace Lipid mediators of inflammation in gastric ulcer Am J Physiol 258 1 Pt 1 1990 G1 G11
46. M.L. Schwartzman, P. Iserovich, K. Gotlinger, and et al. Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy Diabetes 59 2010 1780 1788